Robbins Essential Pathology Lung and Upper Respiratory Tract PDF

Summary

This chapter from the book "Robbins Essential Pathology" focuses on the Lung and Upper Respiratory Tract, including pathogenesis, morphology, clinical features of malignant mesothelioma, and nasopharyngeal carcinoma. It provides detailed information on the diseases.

Full Transcript

CHAPTER 10 Lung and Upper Respiratory Tract 185 Pathogeness. Once nae...

CHAPTER 10 Lung and Upper Respiratory Tract 185 Pathogeness. Once naed, asbesos ibers reman n e body or e, Clncal Features. Magnan mesoeoma s a ea umor. e and e eme rsk ater exposure does no dmns over me. Asbes- medan sur vva s ess an 1 year n unreaed paens and ony os occurs n wo dsnc geomerc orms, ser pentne and ampboe sgy greaer n reaed paens. Because e umor encases e (needeke). Ampboes are more paogenc an serpenne orms, ung, surgca resecon requres remova o e enre ung and peura peraps because e srag ibers agn w e arsream and are (exrapeura pneumonecomy). Combnaon cemoerapy exends devered more deepy no e ungs. I s ypoeszed a asbesos e, bu ony by a maer o mons. ibers preerenay accumuae n aveo a e perper y, near e Nasopharyngeal Carcinoma mesoea ce ayer, were ey nduce e producon o reacve oxygen speces a cause DNA damage and muaons. Sequencng o Nasopar yngea carcnoma s a rare neopasm a mers a bre mesoeoma genomes as reveaed mupe drver muaons, many commen because o s srong assocaon w Epsen-Barr vrus o wc cuser n paways nvoved n DNA repar, ce cyce conro, (EBV) and s g requency among e Cnese, rasng e possby and grow acor sgnang. One o e mos commony muaed genes o vra oncogeness on a background o genec suscepby. e EBV n sporadc mesoeoma, BAP1, encodes a umor suppressor nvoved genome s ound n vruay a nasopar yngea carcnomas, ncudng n DNA repar a aso s afeced by germne muaons n ames ose a occur ousde e endemc areas n Asa. I s oug w a g ncdence o mesoeoma. a EBV necs e os by irs repcang n e nasopar yngea epeum, and n some ndvduas, s may ead o ransormaon o e epea ces. e umor ypcay s composed o arge epea Morphology. Magnan mesoeomas are oten preceded by ces w ndsnc ce borders and promnen nuceo (Suppemena peura ibross and paque formaton, bo ready seen on magng. eFg. 10.17). ere oten s a srkng nux o nraumora T ces, Once esabsed, e umor spreads aong e peura wdey, eer wc are beeved o be respondng o vra angens. by conguous grow or by e dfuse seedng o peura suraces. Nasopar yngea carcnomas nvade ocay, spread o cer vca A auopsy, e afeced ung ypcay s encased n a ayer o yeow- ymp nodes, and en measasze o dsan ses. ey end o be we, irm umor a oberaes e peura space (Fg. 10.22). radosensve, and 5-year sur vva raes o 50% are repored even or e neopasm may be ocay nvasve, bu dsan measases are paens w cancers a ave spread ocay. ey aso are gy uncommon. Norma mesoea ces are bpasc, gvng rse responsve o mmune ceckpon nbors, provdng a new er- o peura nng ces, as we as e underyng ibrous ssue. In apeuc sraeg y or umors a do no respond o convenona ne w s poena, mesoeomas conorm o one o ree erapy. morpoogc appearances: (1) epea; (2) sarcomaous, n wc Carcinoma of the Larynx spnded, occasonay ibrobasc-appearng ces grow n sees; and (3) bpasc, avng bo sarcomaous and epea areas. Nearly all cases of laryngeal carcinoma occur in smokers. Carcnoma o e ar ynx represens ony 2% o a cancers. I mos commony occurs ater 40 years o age and s more common n men an n women. In addon o smokng, acoo consumpon and asbesos exposure are assocaed w ncreased rsk. Human papo- mavrus (HPV) genomes are presen n abou 15% o umors, and ese umors ave a beer prognoss an ose a are HPV-negave. Mos ar yngea cancers are ypca squamous ce carcnomas. Carcnoma o e ar ynx maness cncay w perssen oarseness. e ocaon o e umor wn e ar ynx as a sgni- can bearng on e prognoss. Goc umors are oten sympomac eary n er course due o efecs on speec, and spread beyond e ar ynx s uncommon. In conras, e supragoc ar ynx s rc n ympac spaces, and neary one rd o ese umors measasze o regona (cer vca) ymp nodes, and subgoc umors end o pro- duce sympoms ony ater ey ave spread. W surger y, radaon erapy, or combnaon reamen, many paens can be cured, bu abou one rd de o e dsease. e usua cause o dea s wde- spread measases and cacexa, somemes compcaed by pumo- nar y necon. Fig. 10.22 Malignant mesothelioma. Note the thick, firm, white pleural tumor that encases this bisected lung. CHAPTER 10 Lung and Upper Respiratory Tract 185.e1 Supplemental eFig. 10.17 Nasopharyngeal carcinoma, undifferenti- ated type. The syncytium-like clusters of epithelium are surrounded by lymphocytes. 11 Kidney O U T L I N E Overview of Renal Diseases, 186 Diseases of Tubules and Interstitium, 195 Diseases of Glomeruli, 187 Acute Pyelonephritis, 195 Mechanisms of Glomerular Injury, 187 Chronic Pyelonephritis, 196 Minimal Change Disease, 187 Drug-Induced Tubulointerstitial Nephritis, 197 Membranous Nephropathy, 187 Acute Tubular Injury, 197 Focal Segmental Glomerulosclerosis, 189 Cystic Diseases, 198 Membranoproliferative Glomerulonephritis, Diseases of Blood Vessels, 199 191 Nephrosclerosis, 199 C3 Glomerulopathies, 191 Malignant Hypertension, 199 Diabetic Nephropathy, 191 Thrombotic Microangiopathies, 199 Acute Poststreptococcal Glomerulonephritis, 192 Renal Stones (Urolithiasis), 201 Lupus Nephritis, 193 Hydronephrosis, 202 Rapidly Progressive Glomerulonephritis, 193 Tumors of the Kidney, 202 IgA Nephropathy, 194 Renal Cell Carcinoma, 202 Hereditary Nephritis, 194 Wilms Tumor, 203 Table 11.1 Glomerular Sy ndr ome s OVERVIEW OF RENAL DISEASES Syndrome Manifestations The majo r diseases of th e k i dn e y i n i ti a ll y involve o ne of the fo u r Nephritic syndrome Hematuria, azotemia, variable proteinuria, main structural ren a l co mp o n en ts , bu t in a ll d i s e a se s , a ll o th e r oliguria, edema, and hypertension components of the k i d n ey ma y be a ff e c t e d s e c o n da r i ly. Rapidly progressive Acute nephritis, proteinuria, and acute he our man srucura componens o e kdney are: glomerulonephritis renal failure    Gomeru, uncona uns a er e bood, reanng macro- Nephrotic syndrome >3.5 gm/day proteinuria, hypoalbumin- moecues and ces and excreng soube maeras and lud (Sup- emia, hyperlipidemia, lipiduria pemena eFg. 11.1) Chronic renal failure Azotemia → uremia progressing for    Tubues, wc conro e amoun o lud, ons, and sma moecues months to years a are excreed by reguang e reabsorpon o ese subsances    he ntersttum, wc provdes e supporng scafod Isolated urinary Glomerular hematuria and/or subne- abnormalities phrotic proteinuria    Bood vesses, wc dever arera bood o be ered and reurn venous bood o e crcuaon Acute kidney injury (not listed) is most often the result of diseases affecting tubules. R ena  njur y c aus e d by d   eren me cansms ends o preere n -   a  y a e c  p ar  c u  ar s r u c u res ; or ex ampe, g omer u  ar d s e as e s are o en mmunoog  c a  y me d  ae d, w ere as ubu  ar and  ners -    Rena faure s e oss o rena uncon. Acute rena faure s e cn- a ds orders are more  key o be c aus e d by ox  c or  n e c   ous ca sae a resus rom rapdy deveopng rena njury. I may pres- agens. We w  ereore d s c uss  ndv du a  d s e as es by o c us  ng on en w reduced or no urne oupu (ogura or anura, respecvey),  e pr mar y se o rena   nju r y, re c og n  z ng  a b e c aus e  e com- yperenson, and oer sgns o rena dysuncon. Laboraory ess p onens o  e k dne y are  u nc   ona  y   n ke d, as d s e as e adv anc e s revea an ncrease n bood urea nrogen (BUN) and serum creanne, a p ar s o  e k dne y may be a e c e d. I s a s o  mp or  an o appre - coecvey ermed azotema. hese canges are caused by a reduced c ae  a  e k dne y as a  arge  u nc   ona  res er ve;  us , e ary sg ns gomeruar raon rae (GFR), wc may resu rom nrnsc ds- o k dne y ds e as e are o en mss e d, and sub s an  a  d amage may eases o e kdney (e.g., gomeruar or ubuar dseases) or exrarena o cc ur b eore rena  dy s  unc   on b e come s c n  c a  y app aren. causes (e.g., severe yperenson or emoyc-uremc syndrome). he Renal diseases manifest with different clinical syndromes (Table 11-1). causave abnormaes ousde e kdney may be prerena (reduced he naure o e syndrome oten provdes vauabe cues abou e lud voume and, ereore, reduced gomeruar peruson) or pos- underyng dagnoss and, ereore, e mos efecve erapy. he rena (obsrucon o e oulow rac). Wen e azoema s severe major rena syndromes a no severa broad caegores. enoug o cause cnca sgns and sympoms, e erm urema s used. 186 GLOMERULUS Capillary Urinary space loops Mesangium Mesangial cell Mesangial matrix Red cell Parietal epithelium Fenestrae in Proximal endothelium tubule Urinary space Capillary lumen Parietal epithelium Basement membrane Visceral epithelium Endothelium Foot processes Basement membrane Red blood cell B Foot processes Supplemental eFig. 11.1 Schematic representation of a lobe of a glomerulus. 186.e1 CHAPTER 11 Kidney 187 oer nsances, dependng on e makeup and anaomc ocaon    Acute kdney njur y reers o abrup onse o azoema w o e deposs, ey may nsead dsrup e gomeruar permea- ogura or anura. I s mos oten caused by severe ubuar by barrer wou causng nlammaon (neproc syndrome). njur y (prevousy caed acute tubuar necross, or ATN), bu    D eposton of ant-GBM antbody. Less requeny, anbodes bnd aso may resu rom acue, usuay severe, njur y o gomeru, o angens a are eveny dsrbued aong e GBM, resung n vesses, or e nersum. a near paern o mmunoluorescen sanng (e.g., Goodpasure    Rapdy progressve gomeruoneprts (RPGN) s a dsnc syndrome). he subsequen njur y s caused by nlammaon rg- eny a aso can cause acue rena aure. gered by compemen and Fc recepor–dependen mecansms, as    Neprotc syndrome as dverse causes a sare a common pao- n mmune compex dseases. pysoogy : a derangemen n e capary was o e gomeru a    Oter mecansms of gomeruar njur y. Some dseases are caused resus n ncreased permeaby o pasma proens and proenura by deecve reguaon o compemen acvaon, resung n (urnary proen oss >3.5g/24 ours). he proen oss eads o ypo- unconroed deposon o pronlammaor y compemen producs abumnema, wc reduces e pasma cood osmoc pressure, n e gomeruus. In oer cases, epea ces (podocyes) a and e resung ransudaon o lud across sma bood vesses pro- ne e gomeruar capar y wa may be njured (e.g., by oxns or duces generazed edema. Hyperpdema s aso oten seen. here s unknown causes), or abnorma gomeruar permeaby may be e requeny reenon o sa and waer, wc exacerbaes e edema. resu o muaons n genes encodng proens o e s dapragm    Neprtc syndrome s caused by nlammaory esons o e gomeru- (e raon membrane o e oo processes o e podocyes). us (ence e erm neprts), caracerzed by emaura, azoema, Podocyes are nmaey nvoved n mananng e barrer unc- and yperenson. I s seen n dseases n wc gomeruar nlamma- on o e GBM, and podocye abnormaes are a vruay unver- on s promnen. Proenura,  presen, s modes. sa eaure o dseases assocaed w neproc syndrome.    Cronc kdney dsease s caused by progressve scarrng o e kd- neys and oss o rena parencyma, evenuay resung n eecro- Minimal Change Disease ye and meaboc abnormaes. I s oten asympomac or a ong Minimal change disease is the most common cause of nephrotic me, un urema deveops, bu can be preceded by one o severa syndrome in children; its unique feature is the absence of glomer- cnca syndromes menoned above. I cumnaes n end-stage rena ular pathology by light microscopic evaluation. dsease, wc can be reaed ony by dayss or ranspanaon.    Oter cnca manfestatons o kdney dsease ncude asympom- Pathogeness. here are no deposs o anbodes or mmune com- ac emaura. pexes n e gomeruus, and no nlammaon. B ecause o e eak- ness o e GBM o abumn, a permeaby-nducng crcuang acor s suspeced, bu aemps o deny s eusve cupr ave aed, DISEASES OF GLOMERULI and e paogeness o e dsease remans unknown. Saen eaures o e mos common prmar y gomeruar dseases are Morphology. he gomeru appear norma by g mcroscopy. summarzed n Tabe 11.2. Here we dscuss rs e genera meca- Eecron mcroscopc evauaon reveas dfuse efacemen o nsms o gomeruar njur y and en dseases a are requeny podocye oo processes (Fg. 11.2);  s no known  s s e encounered cncay or a usrae mporan prncpes o pao- cause or consequence o proenura. geness. As we sa see n s dscusson, paoogc anayss o rena bopses s oten e mansay o dagnoss. Clncal Features. he dsease ypcay presens w neproc syn- Mechanisms of Glomerular Injury drome n a prevousy eay cd, mos commony beween e ages Most glomerular diseases are immunological in origin, caused by o 1 and 7 years. Casscay, e proen oss s seecve, prmary o deposition of immune complexes or antibodies in the glomerular ow-moecuar-weg proens suc as abumn. he majory o paens capillary wall (Fig. 11.1). respond we o corcoserod erapy, bu proenura recurs n 60% o    Immune compex deposton. Compexes o angen and anbody na responders, many o wom become serod dependen. In adus are usuay ormed n e crcuaon and are prone o depos n e response o serods s sower and reapses are more common. gomeru because o e g vascuar pressure a drves e - Membranous Nephropathy raon o pasma o orm urne, as we as e negave carge and permeaby caracerscs o e gomeruar basemen membrane Membranous nephropathy is caused by immune complex deposition (GBM), wc promoe e sabe aacmen o anbodes. Two in the glomerular capillary wall, resulting in the nephrotic syndrome. nonexcusve mecansms o anbody deposon n e gomer- uus ave been esabsed: (1) deposon o crcuang angen– Pathogeness. In e majory o cases, mmune compexes are ormed n anbody compexes n e gomeruar capar y wa or mesangum stu by auoanbodes bndng o endogenous podocye angens (e.g., pos- (e.g., n sysemc upus er yemaosus [SLE]), and (2) anbodes popase A2 recepor) or paned angens. hus, membranous neprop- reacng n su wn e gomeruus, eer w xed (nrnsc) ay s an auommune dsease, and, ke mos dseases n s group, s gomeruar angens or w exrnsc moecues a are paned eoogy s unknown. In up o 80% o cases, membranous nepropay s n e gomeruus. Wen anbody bndng s pacy (resembng prmary w no assocaed dsease; ess commony,  s seen n assocaon deposon o crcuang compexes)  s caed n stu mmune w oer we-dened auommune dseases, suc as SLE. I may aso be compex ormaon. Immune compex deposs are seen as granu- secondary o necons (e.g., maara, syps, and epas B) or umors ar areas conanng mmunogobun or compemen producs by (e.g., meanoma and carcnomas o e ung and coon), or may occur n mmunoluorescen sanng or as eecron-dense “umpy bumpy” paens akng erapeuc drugs (e.g., pencamne, capopr, nonsero- deposs on e GBM by eecron mcroscopy. Once mmune com- da annlammaory agens); a o ese condons may ec anbodes pexes are ormed n e gomeruus, ey may acvae e com- a may bnd o angens a are paned n e GBM. he ormaon o pemen sysem and recru eukocyes va compemen producs, subepea mmune deposs eads o compemen acvaon on e sur- as we as by Fc recepor bndng (see Caper 4), resung n oca ace o podocyes and generaes e membrane aack compex (C5 o C9). nlammaon (gomeruoneprs w neprc syndrome). In hs n urn causes podocye and GBM njury and proenura. 188 CHAPTER 11 Kidney Table 11.2 Summary of Major Primary Glomerular Diseases Glomerular Pathology Most Frequent Fluorescence Disease Clinical Presentation Pathogenesis Light Microscopy Microscopy Electron Microscopy Minimal change Nephrotic syndrome Unknown; permeability- Normal Negative Loss of foot processes; disease inducing factor? no deposits Membranous Nephrotic syndrome Deposition of immune Diffuse GBM thick- Granular deposits of IgG Subepithelial deposits nephropathy complexes; in most cases ening and C3; diffuse with interspersed of primary disease the spikes of GBM antigen is unknown material; loss of foot processes Diabetic Nephrotic syndrome Unclear; may include GBM thicken- Nonspecific GBM thickening nephropathy increased synthesis of ing, mesangial GBM material stimulated by sclerosis, nodular growth factors; glomerular deposits of matrix hyperfiltration because of material microvascular disease Focal segmen- Nephrotic syndrome, Unknown; podocyte injury, Focal and segmen- Focal IgM + C3 in some Effacement of podo- tal glomer- sometimes with glomerular hyperfiltration? tal sclerosis and cases, reflecting non- cyte foot processes ulosclerosis microscopic accumulation of specific trapping (FSGS) hematuria and matrix material hypertension (“hyaline”) Membranopro- Nephrotic/nephritic Immune complex deposition Proliferation of Granular deposits of IgG Subendothelial depos- liferative glo- syndrome mesangial and and C3 its merulonephri- epithelial cells; tis (MPGN GBM thickening; type I) splitting Dense deposit Nephrotic/nephritic Unregulated activation of Mesangial prolifer- C3; no IgG or C1q Ribbon-like elec- disease syndrome alternative pathway of ative or mem- tron-dense deposits complement because of branoproliferative in GBM autoantibody that binds to patterns of prolifer- and stabilizes C3 conver- ation; GBM thick- tase ening; splitting C3 glomerulo- Nephrotic/nephrotic Same as dense deposit Mesangial prolifer- C3; no IgG or C1q Mesangial and sub- nephritis syndrome disease ative or mem- endothelial elec- branoproliferative tron-dense “waxy” patterns of deposits proliferation Acute post- Nephritic syndrome Immune-complex mediated; Diffuse proliferation Granular deposits of IgG Primarily subepithelial streptococcal circulating or planted of endothelial and and C3 in GBM and humps; subendothe- glomerulone- antigen other glomerular mesangium lial deposits in early phritis cells; leukocytic disease stages infiltration Lupus nephritis Nephrotic or Immune-complex mediated, Variable; diffuse Granular deposits of IgG Subendothelial, subep- nephritic syn- circulating self-antigens proliferative GN and C3 in GBM and ithelial, or mesangial drome (mainly nuclear antigens) or primarily mem- mesangium deposits branous pattern Rapidly Nephritic syndrome, Anti-GBM antibodies Extracapillary prolif- Linear IgG and C3, Typically no deposits; progressive renal failure (Goodpasture syndrome), eration with cres- immune complexes, GBM disruptions; glomeru- immune complexes, (in cents; necrosis or negative in differ- fibrin lonephritis association with other dis- ent forms; fibrin in (RPGN) ease such as SLE) or “pau- crescents ci-immune” (sometimes with ANCA vasculitis) IgA nephrop- Recurrent hematuria Unknown Focal mesangial IgA ± IgG, IgM, and C3 Mesangial and athy or proteinuria proliferative in mesangium paramesangial dense glomerulonephri- deposits tis; mesangial widening Hereditary Proteinuria, hema- Mutation of the genes encod- Glomerulosclerosis No deposits Thinning and lamina- nephritis turia ing the α3, α4, or α5 chain tion of the basement of type IV collagen (Alport membrane syndrome) Diabetic nephropathy is discussed in Chapter 16. FSGS and membranous nephropathy are the most common causes of idiopathic nephrotic syndrome in adults. Their relative incidence varies in different population groups. ANCA, Antineutrophil cytoplasmic antibodies; GN, glomerulonephritis; GBM, glomerular basement membrane.

Use Quizgecko on...
Browser
Browser